Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus. The investigators next plan to test the vaccine in nonhuman primates and humans to see if it is safe and effective in preventing COVID-19 infection.
- Scientists claim controversial results of comets observations are consistent
- The smell of cooperation
- Princeton scientists solve the mystery behind an enigmatic organelle, the pyrenoid
- Princeton scientists discover a motif that guides assembly of the algal pyrenoid
- Neutrinos yield first experimental evidence of catalyzed fusion dominant in many stars